Showing results (281-290 of 933) with videos related to
Sort By:
Pageof 94
Cancer|March 20, 2002
Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimenMary A Weiser, Susan O'Brien, Deborah A Thomas, et al.Advances in Therapy|October 7, 2017
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical ExperienceGilles Salles, Martin Barrett, Robin Foà, et al.Journal of Clinical Pathology|November 24, 2018
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluationPrajwal Boddu, Beenu Thakral, Ahmed Alhuraiji, et al.ISRN Oncology|October 30, 2013
Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolizationMohamed E Salem, Nitin Jain, Gregory Dyson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United StatesQiushi Chen, Nitin Jain, Turgay Ayer, et al.Cancer|May 5, 2025
The evolving therapeutic revolution in adult acute lymphoblastic leukemiaHagop Kantarjian, Nitin Jain, Mark R Litzow, et al.Physical Review Letters|January 18, 2018
Dynamical Transition of Collective Motions in Dry ProteinsZhuo Liu, Juan Huang, Madhusudan Tyagi, et al.Journal of Indian Association of Pediatric Surgeons|August 7, 2026
Genomic Insights into p53 Alterations and Chromosome 1p Anomalies for Prognostic Stratification in Childhood Solid Tumors: A Pilot StudySimmi K Ratan, Nitin Jain, Dinesh Kumar, et al.Cancer|June 16, 2004
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.Cancer|May 26, 2004
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phaseJorge Cortes, Susan O'Brien, Alfonso Quintas, et al.Pageof 94